ENDOMETRIAL MIXED CELL ADENOCARCINOMA
Clinical trials for ENDOMETRIAL MIXED CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL MIXED CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL MIXED CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktails battle tough uterine cancer
Disease control OngoingThis study is testing several drug combinations to see if they work better than single drugs at controlling advanced endometrial cancer that has returned or spread. It involves 288 women whose cancer has come back after prior treatment. Researchers are comparing different pairs o…
Matched conditions: ENDOMETRIAL MIXED CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
Major trial tests new weapon against advanced uterine cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called pembrolizumab to standard chemotherapy works better for treating advanced or recurrent endometrial cancer. It involves over 800 patients with stage III, IV, or returning cancer. The goal is to see…
Matched conditions: ENDOMETRIAL MIXED CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC